Combination effect of regulatory T-cell depletion and ionizing radiation in mouse models of lung and colon cancer

International Journal of Radiation Oncology, Biology, Physics
Cheol-Hun SonYou-Soo Park

Abstract

To investigate the potential of low-dose cyclophosphamide (LD-CTX) and anti-CD25 antibody to prevent activation of regulatory T cells (Tregs) during radiation therapy. We used LD-CTX and anti-CD25 monoclonal antibody as a means to inhibit Tregs and improve the therapeutic effect of radiation in a mouse model of lung and colon cancer. Mice were irradiated on the tumor mass of the right leg and treated with LD-CTX and anti-CD25 antibody once per week for 3 weeks. Combined treatment of LD-CTX or anti-CD25 antibody with radiation significantly decreased Tregs in the spleen and tumor compared with control and irradiation only in both lung and colon cancer. Combinatorial treatments resulted in a significant increase in the effector T cells, longer survival rate, and suppressed irradiated and distal nonirradiated tumor growth. Specifically, the combinatorial treatment of LD-CTX with radiation resulted in outstanding regression of local and distant tumors in colon cancer, and almost all mice in this group survived until the end of the study. Our results suggest that Treg depletion strategies may enhance radiation-mediated antitumor immunity and further improve outcomes after radiation therapy.

References

Jan 21, 2006·Seminars in Cancer Biology·Rong-Fu Wang
Mar 25, 2006·Nature Reviews. Immunology·Weiping Zou
May 25, 2006·Mini Reviews in Medicinal Chemistry·Dominik WolfAnna-Maria Wolf
Mar 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nancy J NesslingerBrad H Nelson
May 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·Noriko Komatsu, Shohei Hori
Feb 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·F Stephen HodiGlenn Dranoff
Mar 5, 2008·Clinical & Developmental Immunology·Nathalie CoolsZwi N Berneman
Jul 4, 2009·The Lancet Oncology·Silvia C Formenti, Sandra Demaria
Dec 3, 2009·Journal of Immunotherapy·Pu LiuKarl Erik Hellstrom
Nov 26, 2010·International Journal of Radiation Oncology, Biology, Physics·Evelyn L KachikwuDörthe Schaue
May 26, 2011·Seminars in Immunopathology·Antonella SistiguLaurence Zitvogel
May 3, 2012·Cancer Research·Andrea FacciabeneGeorge Coukos
Oct 16, 2013·The Journal of Experimental Medicine·Paula D BosAlexander Y Rudensky
Jan 18, 2014·International Journal of Molecular Sciences·Bonggoo ParkKyung-Mi Lee

❮ Previous
Next ❯

Citations

Jul 22, 2017·Journal of Cellular Biochemistry·Jian Y ZouZhen G Chen
May 11, 2016·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Hyunseong KimHyunsu Bae
Jun 24, 2017·Frontiers in Immunology·Sebastian Diegeler, Christine E Hellweg
Oct 13, 2018·Radiation Oncology Journal·Jae Ho KimStephen L Brown
Jul 1, 2016·International Journal of Particle Therapy·Takashi ShimokawaTakashi Imai
Jun 12, 2019·Journal of Oncology·Malek KreidiehAli Shamseddine
Jun 20, 2017·Integrative Cancer Therapies·Anita Thyagarajan, Ravi P Sahu
Jun 14, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Luis De La MazaMarc de Perrot
May 10, 2020·Seminars in Radiation Oncology·Michael J GoughKristina H Young
Jan 23, 2021·Critical Reviews in Oncology/hematology·Michael I Koukourakis, Alexandra Giatromanolaki
Feb 22, 2021·Seminars in Radiation Oncology·Peter H GoffStephanie K Schaub

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.